Woolsey received three new U.S. patents covering innovations related to ROCK inhibitor Bravyl (oral fasudil), its ...

The senior community is vastly underserved when it comes to recreational activities, and we know that exercise keeps our ...

The Lancet Neurology has published a research article assessing the number and frequency of blows to the head during four ...

Brooke Eby, who is 35 and has ALS, is teaching us what it means to live when you know your time of death is coming sooner ...

Woolsey Pharmaceuticals today announced the recent issuance of three key patents that cover cutting-edge innovations related ...

The first patient has been dosed in an open-label Phase 1/2 clinical trial of AMT-162, uniQure's one-time gene therapy for ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This process results in deterioration of muscle strength in the limbs and bulbar ...

A robust EMS system is essential for health and safety, yet we face service gaps in our county,” said an Ulster County government release last week. “The 2025 executive budget includes a package of ...

Providence Health & Services is eliminating several Portland-area nurses and communication specialists who serve patients ...

NP001 is an investigational treatment that, if approved, could be the first disease-modifying therapy for ALS that restores balance over uncontrolled inflammation within the body’s own innate immune ...

Corcept could be significantly undervalued based on long term potential growth and science-based innovation. Find out why ...

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability of resp ...